EUVIMEDEUVIMED entdecken
Open Access

Blood Biomarkers and the Risk of Coronary Disease in Atrial Fibrillation

Andres Cordova Sanchez iD, Katherine Wilkinson iD, Samuel A P Short iD, Virginia J Howard iD, Suzanne E Judd iD, Parag Goyal iD, Elsayed Z Soliman iD, Emily B Levitan iD, Monika M Safford iD, Mary Cushman iD

Journal of the American Heart Association · 05.05.2026 · 15 (9)

DOI: 10.1161/jaha.125.045735 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of the American Heart Association, erschienen am 05.05.2026. Verfasst von Andres Cordova Sanchez und 9 weiteren Autor:innen. Beteiligte Einrichtung: University of Vermont Larner College of Medicine Burlington VT USA. Hauptthemen laut MEDLINE: Atrial Fibrillation, Coronary Disease. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Atrial fibrillation (AF) is the most common arrhythmia. Although it was recently identified as a risk factor for coronary heart disease (CHD), the underlying pathophysiology is not well understood. Biomarkers could provide insights on underlying mechanisms and identify potential predictors of CHD among people with AF.

Methods

The REGARDS (Reasons for Geographic and Racial Differences in Stroke) cohort study enrolled 30 239 White and Black adults aged 45 and older in 2003 to 2007. Among those with baseline AF and no history of stroke or CHD, 13 cardiovascular risk biomarkers were measured at baseline. We calculated hazard ratios (HR) for incident CHD by biomarkers using Cox proportional hazards model adjusting for risk factors and use of statins, aspirin, and anticoagulants.

Results

Among 1818 participants with prevalent AF mean age was 69 years (SD 10 years). There were 201 (11%) cases of incident CHD over 9 years. Several biomarkers were associated with incident CHD: NT‐proBNP (N‐terminal pro‐B‐type natriuretic peptide), GDF‐15 (growth differentiation factor 15), C‐reactive protein, interleukin‐6, D‐dimer, cholesterol, lipoprotein(a), triglycerides, low‐density lipoprotein, and gamma‐glutamyl transferase, with HRs 1.17 to 1.69 per SD increment. There were no associations for Factor VIII, galectin 3, and high‐density lipoprotein. The largest associations were for NT‐proBNP and GDF‐15 with respective HRs per SD 1.69 (95% CI, 1.42–2.01) and 1.45 (95% CI, 1.21–1.74). Comparing the top versus bottom tertile, the largest associations were NT‐proBNP (HR 3.14 [95% CI 2.03–4.84]), interleukin‐6 (HR, 2.69 [95% CI, 1.78–4.06]), and GDF‐15 (HR, 2.20 [95% CI, 1.38–3.51]).

Conclusions

Multiple biomarkers were associated with incident CHD in AF with the largest associations being myocardial strain and inflammation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Atrial FibrillationCoronary DiseaseAgedFemaleHumansMaleMiddle AgedBiomarkersBlack or African AmericanC-Reactive ProteinFibrin Fibrinogen Degradation ProductsGrowth Differentiation Factor 15IncidenceInterleukin-6Lipoprotein(a)Natriuretic Peptide, BrainPeptide FragmentsProportional Hazards ModelsProspective StudiesRisk AssessmentRisk FactorsUnited States

Stichwörter der Autor:innen

atrial fibrillationbiomarkerscoronary heart diseaseinflammationrisk factors

Substanzen

BiomarkersC-Reactive ProteinFibrin Fibrinogen Degradation Productsfibrin fragment DGDF15 protein, humanGrowth Differentiation Factor 15Interleukin-6Lipoprotein(a)Natriuretic Peptide, BrainPeptide Fragments

Autor:innen und Institutionen

  • University of Vermont Larner College of Medicine Burlington VT USA.
  • UNC Health Chapel Hill NC USA.
  • University of Alabama at Birmingham Birmingham AL USA.
  • Weill Cornell Medicine New York NY USA.
  • Wake Forest School of Medicine Winston-Salem NC USA.

ORCID-Profile: Andres Cordova Sanchez, Katherine Wilkinson, Samuel A P Short, Virginia J Howard, Suzanne E Judd, Parag Goyal, Elsayed Z Soliman, Emily B Levitan, Monika M Safford, Mary Cushman

Zitieren

APA

Cordova Sanchez, A., Wilkinson, K., Short, S. A. P., Howard, V. J., Judd, S. E., Goyal, P., Soliman, E. Z., Levitan, E. B., Safford, M. M., & Cushman, M. (2026). Blood Biomarkers and the Risk of Coronary Disease in Atrial Fibrillation. Journal of the American Heart Association, 15(9). https://doi.org/10.1161/jaha.125.045735

Vancouver

Cordova Sanchez A, Wilkinson K, Short SAP, Howard VJ, Judd SE, Goyal P, et al. Blood Biomarkers and the Risk of Coronary Disease in Atrial Fibrillation. Journal of the American Heart Association. 2026;15(9). doi:10.1161/jaha.125.045735

BibTeX
@article{CordovaSanchez2026,
  author = {Cordova Sanchez, Andres and Wilkinson, Katherine and Short, Samuel A P and Howard, Virginia J and Judd, Suzanne E and Goyal, Parag and Soliman, Elsayed Z and Levitan, Emily B and Safford, Monika M and Cushman, Mary},
  title = {Blood Biomarkers and the Risk of Coronary Disease in Atrial Fibrillation},
  journal = {Journal of the American Heart Association},
  year = {2026},
  volume = {15},
  number = {9},
  doi = {10.1161/jaha.125.045735}
}
Kostenlos starten →